40
Participants
Start Date
March 31, 1998
Primary Completion Date
March 31, 2001
Study Completion Date
March 31, 2001
irinotecan hydrochloride
CCOP - Ann Arbor Regional, Ann Arbor
CCOP - Metro-Minnesota, Saint Louis Park
Mayo Clinic Cancer Center, Rochester
CentraCare Clinic, Saint Cloud
Rapid City Regional Hospital, Rapid City
CCOP - Merit Care Hospital, Fargo
Altru Health Systems, Grand Forks
Quain & Ramstad Clinic, P.C., Bismarck
CCOP - Illinois Oncology Research Association, Peoria
CCOP - Carle Cancer Center, Urbana
CCOP - Missouri Valley Cancer Consortium, Omaha
CCOP - Ochsner, New Orleans
CCOP - Scottsdale Oncology Program, Scottsdale
CCOP - Cedar Rapids Oncology Project, Cedar Rapids
CCOP - Iowa Oncology Research Association, Des Moines
Siouxland Hematology-Oncology, Sioux City
CCOP - Wichita, Wichita
CCOP - Toledo Community Hospital Oncology Program, Toledo
CCOP - Geisinger Clinic and Medical Center, Danville
CCOP - Sioux Community Cancer Consortium, Sioux Falls
Saskatchewan Cancer Agency, Regina
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER